We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

126 hedge funds and large institutions have $282M invested in Akebia Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 36 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 36

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9% less funds holding

Funds holding: 139 → 126 (-13)

9.88% less ownership

Funds ownership: 66.31% → 56.43% (-9.9%)

16% less call options, than puts

Call options by funds: $1.52M | Put options by funds: $1.8M

29% less capital invested

Capital invested by funds: $399M → $282M (-$118M)

50% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 22

Holders
126
Holders Change
-13
Holders Change %
-9.35%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
49
Reduced
36
Closed
22
Calls
$1.52M
Puts
$1.8M
Net Calls
-$280K
Net Calls Change
+$1.19M

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$8.16M
2
WP
Woodline Partners
California
+$6.28M
3
State Street
State Street
Massachusetts
+$5.28M
4
Prudential Financial
Prudential Financial
New Jersey
+$3.03M
5
BlackRock
BlackRock
New York
+$2.51M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$40.7M
2
Goldman Sachs
Goldman Sachs
New York
-$7.4M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$3.74M
4
Morgan Stanley
Morgan Stanley
New York
-$3.39M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
KWM
101
Kingsview Wealth Management
Oregon
$32K -$9.84K -3,445 -24%
AWM
102
AE Wealth Management
Kansas
$30K – – –
Canada Life
103
Canada Life
Manitoba, Canada
$21K – – –
PCM
104
Penserra Capital Management
California
$11K +$999 +350 +10%
OSAM
105
O'Shaughnessy Asset Management
Connecticut
$10K -$32.3K -11,314 -77%
Fifth Third Bancorp
106
Fifth Third Bancorp
Ohio
$10K – – –
Macquarie Group
107
Macquarie Group
Australia
$10K – – –
S
108
SignatureFD
Georgia
$6K +$1.94K +678 +44%
Rockefeller Capital Management
109
Rockefeller Capital Management
New York
$5K – – –
Osaic Holdings
110
Osaic Holdings
Arizona
$3K -$34.5K -12,093 -93%
TC
111
Truvestments Capital
Florida
$3K – – –
BWP
112
Baldwin Wealth Partners
Massachusetts
$2K – – –
CG
113
Cutler Group
California
$2K – – –
EI
114
Ellevest Inc
New York
$2K +$297 +104 +16%
ED
115
Exane Derivatives
France
$1.36K – – –
Nisa Investment Advisors
116
Nisa Investment Advisors
Missouri
$1.04K – – –
Daiwa Securities Group
117
Daiwa Securities Group
Japan
$1K – – –
HCP
118
Hexagon Capital Partners
Arkansas
$1K – – –
IA
119
IFP Advisors
Florida
$1K +$143 +50 +49%
Walleye Capital
120
Walleye Capital
New York
$796 -$132K -46,193 -14%
FDCDDQ
121
Federation des caisses Desjardins du Quebec
Quebec, Canada
$432 – – –
Wellington Management Group
122
Wellington Management Group
Massachusetts
– -$40.7M -10,736,859 Closed
MFS
123
Mirabella Financial Services
United Kingdom
– -$1.01M -267,603 Closed
Millennium Management
124
Millennium Management
New York
– -$1M -264,954 Closed
HF
125
HRT Financial
New York
– -$236K -62,446 Closed
2 3 4
5
6

AKBA Hedge Fund Activity: Q3 2021 in Review

126 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q3 2021, worth a combined $282M — down 29% from $399M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of AKBA and 11 opened new positions — a net loss of 11 holders — while 36 trimmed existing stakes and 49 added.

The largest buyer was Marshall Wace, adding an estimated $8.16M. The largest seller was Wellington Management Group, exiting entirely with an estimated $40.7M sold.

  • 126 institutional investors held Akebia Therapeutics (AKBA) as of Q3 2021, down from 139 in Q2 2021.
  • Funds reported $282M of Akebia Therapeutics stock for Q3 2021, down 29% quarter-over-quarter.
  • 11 funds opened new Akebia Therapeutics positions in Q3 2021 and 22 closed out, a net change of -11 holders.
  • The largest Akebia Therapeutics buyer in Q3 2021 was Marshall Wace, an estimated $8.16M added.
  • The largest Akebia Therapeutics seller in Q3 2021 was Wellington Management Group, an estimated $40.7M sold.

Based on aggregated 13F filings for Q3 2021.